RELN and breast cancer: The potential clinical relevance of our findings is supported by our observation that Reelin expression is reduced in basal-like subtypes of breast cancer (which are generally triple-negative), as revealed through analysis of patient data using cBioPortal (Breast Invasive Carcinoma dataset, TCGA, PanCancer Atlas) (Figure 3).